S-1: Synbio International Seeks to Register 364 Million Shares for Resale

Synbio International (formerly Natural Harmony Foods) aims to register up to 364,142,854 shares of common stock for resale by Quick Capital, LLC, stemming from a convertible note, commitment shares, and a warrant.

Summary

• Synbio International, previously known as Natural Harmony Foods, is registering up to 364,142,854 shares of its common stock for resale.
• The shares are linked to a convertible note with a principal amount of up to $555,555.55 issued on April 22, 2024, commitment shares, and a warrant.
• Quick Capital, LLC is identified as the selling stockholder.
• The company will not receive any proceeds from the sale of these shares.
• The filing includes a registration statement on Form S-1 with the SEC.
• The company's common stock is listed on the OTC Markets under the symbol NHYF.
• The company aims to enhance patient outcomes and reduce healthcare costs by developing cutting-edge AI-powered methods to aid in the screening and/or diagnosis of medical conditions.
• The company also acknowledges the thriving nutraceutical markets potential and plans to enter it for early revenue.

Sentiment

Score: 4

Explanation: The document is largely factual, but the company's financial situation and dependence on future funding raise concerns. The potential for dilution and the lack of immediate revenue generation contribute to a neutral to slightly negative sentiment.

Positives

• The company is pursuing registration to allow for resale of shares, potentially increasing liquidity.
• The company is developing AI-powered methods to aid in the screening and/or diagnosis of medical conditions.
• The company plans to enter the nutraceutical market for early revenue.

Negatives

• The company will not receive any proceeds from the sale of shares by the selling stockholders.
• The company has incurred significant operating losses since its inception and anticipates that it will continue to incur losses in the near future.
• The company's independent registered public accounting firm has expressed substantial doubt regarding the company's ability to continue as a going concern in its report on the company's financial statements for the most recent fiscal year.

Risks

• The company has a limited operating history.
• The company is dependent upon management, key personnel, and consultants to execute its business plan.
• The company may be unable to maintain or enhance its product image.
• The company may be unable to protect its Intellectual Property effectively.
• Changes in the economy could have a detrimental impact on the company.
• Additional financing may be necessary for the implementation of the company's growth strategy.
• The company may be unable to manage its growth or implement its expansion strategy.
• The company's business model is evolving.
• The company's business is subject to data security risks, including security breaches.
• Information technology system failures or breaches of the company's network security could interrupt operations and adversely affect the business.
• The company needs to increase brand awareness.
• The company's employees may engage in misconduct or improper activities.
• The company has identified material weaknesses in its internal control over financial reporting (ICFR), and if it fails to establish and maintain effective ICFR, its ability to accurately report its financial results could be adversely affected.
• There is substantial doubt about the company's ability to continue as a going concern.
• The company may undertake additional equity or debt financing that would dilute the shares in this offering.
• An investment in the shares is speculative and there can be no assurance of any return on any such investment.
• The company has not paid dividends in the past and does not expect to pay dividends in the future, so any return on investment may be limited to the value of its shares.
• The company may not be able to obtain additional financing.
• The offering price has been already determined.
• An investment in the company's shares could result in a loss of your entire investment.
• You may not be able to liquidate your investment for any reason in the near future.
• There is no guarantee of any return on your investment.
• Sales of a substantial number of shares of the company's stock may cause the price of its stock to decline.
• The company has made assumptions in its projections and in Forward-Looking Statements that may not be accurate.
• You should be aware of the long-term nature of this investment.
• The shares in this offering have no protective provisions.
• You will not have significant influence on the management of the company.
• Our Subscription Agreement identifies the state of Florida for purposes of governing law.

Future Outlook

The company aims to enhance patient outcomes and reduce healthcare costs by developing cutting-edge AI-powered methods to aid in the screening and/or diagnosis of medical conditions. The company also acknowledges the thriving nutraceutical markets potential and plans to enter it for early revenue.

Management Comments

• Natural Harmony Foods Inc (NHYF) aims to enhance patient outcomes and reduce healthcare costs by developing cutting-edge AI-powered methods to aid in the diagnosis of medical conditions.
• NHYF also acknowledges the thriving nutraceutical markets potential and plans to enter it for early revenue.

Industry Context

The company is positioning itself in the growing AI-powered medical technology and nutraceutical markets, aiming to capitalize on the increasing demand for early disease detection and natural health solutions.

Comparison to Industry Standards

• The document does not provide specific comparisons to industry standards or benchmarks.
• Without specific details on the AI technology's performance or the nutraceutical product's efficacy, it's difficult to assess the company's competitive positioning against industry leaders.
• Comparable companies in the AI-driven diagnostics space include firms like PathAI and Paige, while nutraceutical competitors range from large corporations like Nestle to smaller, specialized brands.

Management Changes

Related Party Transactions

• The company's operations are being funded by its CEO and Preferred Shareholder, Mr. Solitario.
• Mr Solitario has contributed a total of $110,744 to cover operating expenses of the Company.
• Mr Solitario earned $75,000 in compensation expense during the six months ended June 30, 2024.

Stakeholder Impact

• Existing shareholders face potential dilution from the issuance of shares related to the convertible note and warrant.
• The company's ability to execute its business plan and generate revenue will impact its employees and potential customers.
• The company's financial stability and ability to meet its obligations will affect its creditors and suppliers.

Next Steps

• The company needs to secure the effectiveness of the registration statement with the SEC.
• The company needs to execute its business plan to generate revenue and improve its financial position.
• The company needs to manage its capital structure and potential dilution from the convertible note and warrant.

Key Dates

Keywords

Registration Statement, Resale, Common Stock, Convertible Note, Warrant, Quick Capital, Synbio International, NHYF